Pan-Class I亚型PI3K/mTOR抑制剂PF-05212384联合克唑替尼在卵巢癌异种移植物和PDX1中的活性

{"title":"Pan-Class I亚型PI3K/mTOR抑制剂PF-05212384联合克唑替尼在卵巢癌异种移植物和PDX1中的活性","authors":"A. Iezzi, E. Caiola, M. Broggini","doi":"10.1016/j.tranon.2016.08.011","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23244,"journal":{"name":"Translational Oncology","volume":"9 1","pages":"458 - 465"},"PeriodicalIF":4.5000,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.tranon.2016.08.011","citationCount":"8","resultStr":"{\"title\":\"Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX1\",\"authors\":\"A. Iezzi, E. Caiola, M. Broggini\",\"doi\":\"10.1016/j.tranon.2016.08.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23244,\"journal\":{\"name\":\"Translational Oncology\",\"volume\":\"9 1\",\"pages\":\"458 - 465\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2016-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.tranon.2016.08.011\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.tranon.2016.08.011\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.tranon.2016.08.011","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}